Sign Up
OverviewAPI
BostonGene is recognized as a leader in AI-driven drug repurposing, utilizing machine learning to identify new drug applications. The company's CEO, Andrew Feinberg, emphasizes their commitment to advancing research and improving patient outcomes through precision medicine.

Ask a question